One of these two forms of vitamin B12 exists in human cells and the other is a manufacturing convenience. That sounds decisive and mostly is not. Here is what the chemistry establishes, what the evidence does not, and why a formula would still choose.
Four forms, one vitamin
Vitamin B12 is a cobalt atom held inside a large ring, with one variable group attached above it. Change that group and the name changes; the rest of the molecule does not.
| Form | Group attached to the cobalt | Occurs in human cells? | Where it is met |
|---|---|---|---|
| Methylcobalamin | A methyl group | Yes — an active coenzyme | Supplements; found in plasma |
| Adenosylcobalamin | An adenosyl group | Yes — an active coenzyme | Supplements; found in tissue |
| Hydroxocobalamin | A hydroxyl group | Yes, as a transit form | Mainly injections |
| Cyanocobalamin | A cyanide group | No | Most supplements and fortified foods |
Where cyanocobalamin comes from
A purification artifact that stuck
Cyanocobalamin is not found in food or in human tissue. It arises during the isolation of B12 from bacterial culture, where cyanide is used in processing and binds tightly to the cobalt.
Why it became the default anyway
Because the same tight bond makes it the most stable of the four. It tolerates light, heat and shelf time better than the coenzyme forms, it is cheaper to manufacture, and it is the form behind most of the last seventy years of clinical use.
That is a genuinely strong position, and any argument against cyanocobalamin has to get past it rather than around it.
What B12 actually does
In human metabolism it is a cofactor for exactly two enzymes. Not dozens — two.
In the cytosol
Methionine synthase converts homocysteine to methionine, and its cofactor is methylcobalamin. When this reaction runs poorly, homocysteine accumulates.
In the mitochondria
Methylmalonyl-CoA mutase handles a step in the breakdown of certain fats and amino acids, and its cofactor is adenosylcobalamin. When this one runs poorly, methylmalonic acid accumulates.
Those two accumulating compounds are how B12 status is assessed in a laboratory, and they are why the two coenzyme forms are both required rather than interchangeable.
The step the marketing skips
Everything is processed to a common intermediate
A swallowed cobalamin does not arrive at an enzyme wearing the group it was sold with. Inside the cell, the upper group is stripped off — the methyl, the adenosyl or the cyanide — producing a bare intermediate. Only then is a new group attached, according to which of the two enzymes needs feeding.
Which is why "pre-methylated" is a misleading phrase
It implies a step has been skipped. The processing happens regardless, and a methylcobalamin capsule does not deliver methylcobalamin intact to methionine synthase.
The honest version is narrower: the removal step differs slightly between forms, and the leftover group differs. That is a real difference. It is a much smaller one than "the body has to convert cyanocobalamin" implies, because the body has to convert all of them.
The cyanide question, in arithmetic
This is the argument most often made against cyanocobalamin, and it deserves a number rather than a shudder.
Cyanocobalamin has a molecular weight of about 1,355. The cyanide group accounts for about 26 of that — under 2% by mass. A 500 microgram dose therefore carries under 10 micrograms of cyanide, which the body disposes of by an ordinary route.
For most people that is not a meaningful exposure, and saying otherwise would be scaremongering. There are specific clinical situations in which prescribers prefer a different form, and that is a conversation with a clinician rather than a decision made in an aisle.
The arithmetic above is arithmetic — molecular weights, not a trial. It is offered as a sense of scale, and it is the reason we do not make an argument out of it.
Absorption is the larger variable
The efficient route saturates
Most B12 is absorbed through a receptor-mediated system that depends on a stomach protein, and that system handles only a very small quantity per dose. Beyond it, absorption falls back on simple diffusion, which is inefficient.
Which is why label doses look absurd
The Daily Value used on US labels is 2.4 micrograms. A supplement printing 500 micrograms is therefore printing a percentage in the tens of thousands, and doing so deliberately: a large dose is how a small diffusion fraction is made to add up.
Absorption efficiency also falls with age and is affected by some long-term medicines. Those variables move the delivered amount far more than the choice between two upper groups does.
What is established, and what is not
| Claim | Status |
|---|---|
| Methylcobalamin and adenosylcobalamin are the two coenzyme forms in human metabolism | Established biochemistry |
| Cyanocobalamin does not occur naturally in the body | Established |
| All forms are processed intracellularly before use | Established |
| Cyanocobalamin is the most stable to light and heat | Established |
| Methylcobalamin is retained differently after a dose | Reported, and we have not read a source we are willing to cite |
| Methylcobalamin produces better outcomes in healthy adults | Not established — we know of no head-to-head trial that shows it |
The last row is the important one. A great deal of copy in this category implies an outcome difference that the published record does not carry, and the implication is usually made by describing the chemistry and letting the reader finish the sentence.
Why a formula would pick one anyway
Three defensible reasons
- It is a form the body uses directly, which is a reasonable default in the absence of a reason to prefer otherwise.
- It carries no group that has to be disposed of, however small that group is.
- It is a checkable disclosure: the word is printed inside the parenthetical, and a buyer can confirm it in seconds.
One reason that is not defensible
Claiming it works better. Nothing in the record supports that, and a brand that says so has told you how it treats the rest of its evidence.
What this looks like on a label
"Vitamin B12 (as methylcobalamin)" or "(as cyanocobalamin)". Same row, same units, one word apart, and no front-of-pack graphic distinguishes them.
It is the same reading skill that separates alpha-GPC from choline bitartrate, and the same one that a proprietary blend defeats — see how to read a Supplement Facts panel in about sixty seconds and what a proprietary blend actually hides.
The checkable version of the question
"Which form is better" cannot be settled from a shelf and, for most people, may not have a large answer. "Which form is in this pack, and did the brand tell me" can be settled in five seconds, and it is the question a label was built to answer.
The same logic runs through the choline pathway, where the form question is much better documented — that is set out in what acetylcholine does, and why choline sits upstream of it.
Where we stand
Weal Focus uses methylcobalamin at 500 micrograms, with the form printed in the panel. We chose it for the three reasons above and not for a fourth one we cannot support.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sources for every figure, with the population studied in each, are on our citations page.